Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FUROSEMIDE Cause Prostatic specific antigen increased? 9 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Prostatic specific antigen increased have been filed in association with FUROSEMIDE (Furosemide). This represents 0.0% of all adverse event reports for FUROSEMIDE.

9
Reports of Prostatic specific antigen increased with FUROSEMIDE
0.0%
of all FUROSEMIDE reports
1
Deaths
2
Hospitalizations

How Dangerous Is Prostatic specific antigen increased From FUROSEMIDE?

Of the 9 reports, 1 (11.1%) resulted in death, 2 (22.2%) required hospitalization.

Is Prostatic specific antigen increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FUROSEMIDE. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does FUROSEMIDE Cause?

Acute kidney injury (7,984) Hypotension (4,468) Dyspnoea (3,559) Fall (3,410) Drug ineffective (3,297) Hyponatraemia (3,127) Hypokalaemia (2,503) Dehydration (2,195) Off label use (2,147) Fatigue (2,107)

What Other Drugs Cause Prostatic specific antigen increased?

ENZALUTAMIDE (3,731) LEUPROLIDE (2,432) ABIRATERONE (1,581) RADIUM RA-223 DICHLORIDE (449) RELUGOLIX (335) BICALUTAMIDE (322) DOCETAXEL (282) APALUTAMIDE (251) DENOSUMAB (220) LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (212)

Which FUROSEMIDE Alternatives Have Lower Prostatic specific antigen increased Risk?

FUROSEMIDE vs FUROSEMIDE\SPIRONOLACTONE FUROSEMIDE vs FUSIDATE FUROSEMIDE vs FUSIDIC ACID FUROSEMIDE vs FUTIBATINIB FUROSEMIDE vs GABAPENTIN

Related Pages

FUROSEMIDE Full Profile All Prostatic specific antigen increased Reports All Drugs Causing Prostatic specific antigen increased FUROSEMIDE Demographics